Reference: 38 CFR 4.104

Sources & Related Guides

What is the VA rating for Aneurysm, Arteriovenous Fistula, Angioneurotic Edema, Erythromelalgia, and Vascular Sarcoma?

Understand guidance under DC 7110 (Aortic aneurysm, a real 100/0 percent split with two textually distinct, unconfirmed post-surgical residual dispatches), DC 7112 (Aneurysm, any small artery, a real 0 percent tier with a fully open symptomatic/post-surgical dispatch), DC 7113 (Arteriovenous fistula, traumatic, a real six-tier ladder confirmed reached by the 38 CFR 4.68 amputation-rule cap), DC 7118 (Angioneurotic edema, a real three-tier ladder with no explicit 0 percent row), DC 7119 (Erythromelalgia, a real four-tier ladder with no explicit 0 percent row, evaluated as a whole rather than per extremity), and DC 7123 (Soft tissue sarcoma, vascular origin, a flat 100 percent tier with a disclosed post-treatment residual dispatch), per COND-082/RSCH-089. This hub closes the final slice of RSCH-040's arteries-and-veins build order.

What is Aneurysm, Arteriovenous Fistula, Angioneurotic Edema, Erythromelalgia, and Vascular Sarcoma?

MOST IMPORTANT TO KNOW FIRST: this hub closes the final slice (slice (e)) of RSCH-040's 5-slice recommended build order for 38 CFR 4.104's 'Diseases of the Arteries and Veins' range (DC 7110-7124), covering the last six diagnostic codes not built anywhere else in this repository: DC 7110 (Aortic aneurysm), DC 7112 (Aneurysm, any small artery), DC 7113 (Arteriovenous fistula, traumatic), DC 7118 (Angioneurotic edema), DC 7119 (Erythromelalgia), and DC 7123 (Soft tissue sarcoma, vascular origin). Together with Peripheral Arterial Disease / Aneurysm / Buerger's Disease (DC 7111/7114/7115), Varicose Veins / Post-Phlebitic Syndrome (DC 7120/7121), Cold Injury Residuals (DC 7122), and Raynaud's Disease / Raynaud's Syndrome (DC 7117/7124), all 14 live diagnostic codes in the DC 7110-7124 range (DC 7101, Hypertension, is already its own separate hub) are now covered somewhere in this repository. DC 7113 computes a clean six-tier ladder. DC 7118 and DC 7119 each compute a real multi-tier ladder but have NO explicit 0 percent row -- a documented case below the lowest stated tier resolves to a disclosed 38 CFR 4.31 no-qualifying-criterion outcome, never a guessed 0 percent. DC 7110 computes a clean 100/0 percent split, but its post-surgical residual language names two textually distinct, unconfirmed destinations that this hub discloses separately rather than guessing or merging into one note. DC 7112 computes only its 0 percent asymptomatic tier; its symptomatic and post-surgical branches are fully open dispatches with no named destination code, disclosed only. DC 7123 computes a flat 100 percent tier during active treatment or within six months of its cessation, with the post-treatment residual determination disclosed rather than computed, matching the already-live Respiratory Neoplasms hub's DC 6819 precedent exactly.

Next steps

What would you like to do with Aneurysm, Arteriovenous Fistula, Angioneurotic Edema, Erythromelalgia, and Vascular Sarcoma?

Save this condition to find it again later. Saved only on this device and browser. Never sent to RatingScope. Lost if you clear browser data or switch devices or browsers.

Overview

How VA describes aortic aneurysm, small artery aneurysm, traumatic arteriovenous fistula, angioneurotic edema, erythromelalgia, and vascular sarcoma severity

MOST IMPORTANT TO KNOW FIRST: this hub closes the final slice (slice (e)) of RSCH-040's 5-slice recommended build order for 38 CFR 4.104's 'Diseases of the Arteries and Veins' range (DC 7110-7124), covering the last six diagnostic codes not built anywhere else in this repository: DC 7110 (Aortic aneurysm), DC 7112 (Aneurysm, any small artery), DC 7113 (Arteriovenous fistula, traumatic), DC 7118 (Angioneurotic edema), DC 7119 (Erythromelalgia), and DC 7123 (Soft tissue sarcoma, vascular origin). Together with Peripheral Arterial Disease / Aneurysm / Buerger's Disease (DC 7111/7114/7115), Varicose Veins / Post-Phlebitic Syndrome (DC 7120/7121), Cold Injury Residuals (DC 7122), and Raynaud's Disease / Raynaud's Syndrome (DC 7117/7124), all 14 live diagnostic codes in the DC 7110-7124 range (DC 7101, Hypertension, is already its own separate hub) are now covered somewhere in this repository. DC 7113 computes a clean six-tier ladder. DC 7118 and DC 7119 each compute a real multi-tier ladder but have NO explicit 0 percent row -- a documented case below the lowest stated tier resolves to a disclosed 38 CFR 4.31 no-qualifying-criterion outcome, never a guessed 0 percent. DC 7110 computes a clean 100/0 percent split, but its post-surgical residual language names two textually distinct, unconfirmed destinations that this hub discloses separately rather than guessing or merging into one note. DC 7112 computes only its 0 percent asymptomatic tier; its symptomatic and post-surgical branches are fully open dispatches with no named destination code, disclosed only. DC 7123 computes a flat 100 percent tier during active treatment or within six months of its cessation, with the post-treatment residual determination disclosed rather than computed, matching the already-live Respiratory Neoplasms hub's DC 6819 precedent exactly.

IMPORTANT DISCLOSURE, READ FIRST: this hub explains the published DC 7110/7112/7113/7118/7119/7123 schedule and common record language. It does not diagnose a condition, determine service connection, infer undocumented findings, estimate an outcome, or replace medical care or accredited representation. ADDITIONAL DISCLOSURES: (1) DC 7110's post-surgical residual language names two textually distinct destinations, neither confirmed: cardiovascular residuals reference 'the General Rating Formula' without naming it, and non-cardiovascular residuals name no destination at all. Both are disclosed separately, never merged into one note, and neither is computed. (2) DC 7112's symptomatic and post-surgical branches are both fully open dispatches to an unnamed body system, disclosed only. (3) DC 7113 is confirmed reached by 38 CFR 4.68's general amputation-rule cap for disabilities of an extremity -- disclosed, not automated, matching this repository's known, repository-wide limitation that 4.68's cap is not computed anywhere yet. (4) DC 7118 and DC 7119 both have no explicit 0 percent row; a documented case below the lowest stated tier resolves to the general 38 CFR 4.31 no-qualifying-criterion rule, never a guessed 0 percent. (5) DC 7119's own Note states its evaluations apply 'as a whole, regardless of the number of extremities involved,' making it NOT eligible for the 38 CFR 4.26 bilateral factor, the same exclusion already disclosed for Raynaud's DC 7117/7124. (6) DC 7123's post-treatment residual determination is disclosed, never computed, the same 'rate on residuals' pattern already live for Respiratory Neoplasms' DC 6819. (7) This hub closes RSCH-040's slice (e), the final slice -- all 14 live diagnostic codes in the DC 7110-7124 range are now covered somewhere across this hub and its four sibling vascular hubs.

Percentage Guides

Understanding Your Percentage

Select a pathway to see what the published criteria ask about, what records may clarify it, and what should not be assumed.

100% (DC 7110)

Highest listed pathway

The aortic aneurysm (ascending, thoracic, or abdominal) is 5 centimeters or larger in diameter, symptomatic, or requires surgery.

What separates the next level: 0 percent applies when none of the three conditions is documented. Once the six-month post-surgical-discharge window closes, DC 7110's Note dispatches to two separate, unconfirmed residual determinations -- see the disclosed gap below.

Review CFR criteria, examples, and evidence
Official CFR language
Evaluate at 100 percent if the aneurysm is any one of the following: Five centimeters or larger in diameter; symptomatic (e.g., precludes exertion); or requires surgery -- 100.
Qualification explanation
Reached when any one of the three listed conditions is documented. This tier also covers the period from a physician's recommendation of surgical correction through six months following hospital discharge, per DC 7110's own Note.
Examples
Imaging documents an abdominal aortic aneurysm measuring 5.4 centimeters in diameter.
Medical evidence
Artery and Vein Conditions DBQ; Imaging (CT, ultrasound, or MRI) documenting aneurysm diameter; Records documenting symptom status or a surgical recommendation
Functional impact examples
A documented aneurysm meeting the size, symptom, or surgical-requirement threshold.
Common misconceptions
This tier is reached by any ONE of the three listed conditions, not all three together.
Related topics
dc7110-two-distinct-dispatches
Source context
38 CFR 4.104; 7110; Current DC 7110 educational pathway. No pending rulemaking found touching this code (RSCH-089).

0% (DC 7110)

Next: 100%

The aortic aneurysm does not meet the size, symptom, or surgical-requirement threshold.

What separates the next level: 100 percent applies once any one of DC 7110's three listed conditions is documented.

Review CFR criteria, examples, and evidence
Official CFR language
Otherwise -- 0.
Qualification explanation
Reached when the aneurysm is smaller than 5 centimeters, asymptomatic, and does not require surgery.
Examples
Imaging documents an abdominal aortic aneurysm measuring 3.1 centimeters, asymptomatic, with no surgery planned.
Medical evidence
Artery and Vein Conditions DBQ; Imaging documenting aneurysm diameter; Records documenting the absence of symptoms or a surgical recommendation
Functional impact examples
A documented aneurysm below the size threshold, without symptoms or a surgical recommendation.
Common misconceptions
This is a real, explicitly stated 0 percent tier, confirmed via two independent primary sources -- not a disclosed gap.
Related topics
dc7110-two-distinct-dispatches
Source context
38 CFR 4.104; 7110; Current DC 7110 educational pathway.

0% (DC 7112, only computable tier)

Highest listed pathway

A small artery aneurysm that is asymptomatic.

What separates the next level: If symptomatic, or following surgery, DC 7112's own Note dispatches to an unnamed body system -- a fully open dispatch this hub discloses but does not compute.

Review CFR criteria, examples, and evidence
Official CFR language
Asymptomatic -- 0.
Qualification explanation
DC 7112's only stated rating tier -- reached when the small artery aneurysm produces no symptoms.
Examples
Imaging documents a small artery aneurysm with no associated symptoms.
Medical evidence
Artery and Vein Conditions DBQ; Imaging documenting the small artery aneurysm and symptom status
Functional impact examples
A documented small artery aneurysm producing no symptoms.
Common misconceptions
DC 7112 (any small artery) is a different code from DC 7111 (any large artery, other than aorta), which is already built in the Peripheral Arterial Disease / Aneurysm / Buerger's Disease hub -- the two are not interchangeable.
Related topics
dc7112-open-dispatch
Source context
38 CFR 4.104; 7112; Current DC 7112 educational pathway.

100% (DC 7113, ceiling tier)

Highest listed pathway

A traumatic arteriovenous fistula with high-output heart failure.

What separates the next level: 60 percent applies without heart failure, but with an enlarged heart, wide pulse pressure, and tachycardia.

Review CFR criteria, examples, and evidence
Official CFR language
With high-output heart failure -- 100.
Qualification explanation
Reached when high-output heart failure is documented as a consequence of the traumatic arteriovenous fistula.
Examples
Cardiology records document high-output heart failure attributed to a documented traumatic arteriovenous fistula.
Medical evidence
Artery and Vein Conditions DBQ; Cardiology records documenting heart failure and its cause
Functional impact examples
Most severe documented finding reachable under DC 7113.
Common misconceptions
DC 7113's tiers are cardiac-status-first, not extremity-first -- the 100 and 60 percent tiers apply regardless of which extremity is affected.
Related topics
dc7113-amputation-rule-cap
Source context
38 CFR 4.104; 7113; Current DC 7113 educational pathway.

60% (DC 7113)

Next: 100%

No heart failure, but an enlarged heart, wide pulse pressure, and tachycardia are documented.

What separates the next level: 100 percent applies once heart failure is also documented; 50 or 40 percent applies once cardiac involvement is absent entirely.

Review CFR criteria, examples, and evidence
Official CFR language
Without heart failure but with enlarged heart, wide pulse pressure, and tachycardia -- 60.
Qualification explanation
Reached when all three findings (enlarged heart, wide pulse pressure, tachycardia) are documented together, without heart failure.
Examples
Cardiology records document an enlarged heart, wide pulse pressure, and tachycardia attributed to a documented traumatic arteriovenous fistula, without heart failure.
Medical evidence
Artery and Vein Conditions DBQ; Cardiology records documenting the three findings
Functional impact examples
Significant documented cardiac involvement, one tier below DC 7113's ceiling.
Common misconceptions
Not yet populated
Related topics
dc7113-amputation-rule-cap
Source context
38 CFR 4.104; 7113; Current DC 7113 educational pathway.

50% (DC 7113, lower extremity)

Next: 60%

No cardiac involvement, but chronic edema, stasis dermatitis, and either ulceration or cellulitis, affecting a lower extremity.

What separates the next level: 40 percent applies for the identical finding in an upper extremity instead; 30 percent applies without ulceration or cellulitis.

Review CFR criteria, examples, and evidence
Official CFR language
Without cardiac involvement but with chronic edema, stasis dermatitis, and either ulceration or cellulitis: Lower extremity -- 50.
Qualification explanation
Reached when chronic edema, stasis dermatitis, and either ulceration or cellulitis are all documented together for a lower extremity, without cardiac involvement.
Examples
Records document chronic edema, stasis dermatitis, and cellulitis in the affected leg, attributed to a documented traumatic arteriovenous fistula, without cardiac involvement.
Medical evidence
Artery and Vein Conditions DBQ; Vascular examination records documenting edema, dermatitis, and ulceration/cellulitis findings by extremity
Functional impact examples
Documented chronic skin and tissue findings in a lower extremity, without cardiac involvement.
Common misconceptions
DC 7113 rates the identical finding differently by extremity (50/30 lower vs. 40/20 upper) -- this is DC 7113's own structure, not a RatingScope assumption.
Related topics
dc7113-amputation-rule-cap
Source context
38 CFR 4.104; 7113; Current DC 7113 educational pathway.

40% (DC 7113, upper extremity)

Next: 60%

No cardiac involvement, but chronic edema, stasis dermatitis, and either ulceration or cellulitis, affecting an upper extremity.

What separates the next level: 50 percent applies for the identical finding in a lower extremity instead; 20 percent applies without ulceration or cellulitis.

Review CFR criteria, examples, and evidence
Official CFR language
Upper extremity -- 40.
Qualification explanation
Reached when chronic edema, stasis dermatitis, and either ulceration or cellulitis are all documented together for an upper extremity, without cardiac involvement.
Examples
Records document chronic edema, stasis dermatitis, and an ulcer in the affected arm, attributed to a documented traumatic arteriovenous fistula, without cardiac involvement.
Medical evidence
Artery and Vein Conditions DBQ; Vascular examination records documenting edema, dermatitis, and ulceration/cellulitis findings by extremity
Functional impact examples
Documented chronic skin and tissue findings in an upper extremity, without cardiac involvement.
Common misconceptions
Not yet populated
Related topics
dc7113-amputation-rule-cap
Source context
38 CFR 4.104; 7113; Current DC 7113 educational pathway.

30% (DC 7113, lower extremity)

Next: 50%

No cardiac involvement, and chronic edema or stasis dermatitis (without ulceration or cellulitis), affecting a lower extremity.

What separates the next level: 50 percent applies once ulceration or cellulitis is also documented; 20 percent applies for the identical finding in an upper extremity instead.

Review CFR criteria, examples, and evidence
Official CFR language
Without cardiac involvement but with chronic edema or stasis dermatitis: Lower extremity -- 30.
Qualification explanation
Reached when chronic edema OR stasis dermatitis (not necessarily both) is documented for a lower extremity, without ulceration, cellulitis, or cardiac involvement.
Examples
Records document chronic edema in the affected leg, attributed to a documented traumatic arteriovenous fistula, without ulceration, cellulitis, or cardiac involvement.
Medical evidence
Artery and Vein Conditions DBQ; Vascular examination records documenting edema or dermatitis findings by extremity
Functional impact examples
DC 7113's lowest stated lower-extremity finding without cardiac involvement.
Common misconceptions
DC 7113's own text names no rating tier at all for a traumatic arteriovenous fistula that is fully asymptomatic, without cardiac involvement and without chronic edema or stasis dermatitis -- this hub only computes the six stated tiers, following the founder-confirmed build scope for this code.
Related topics
dc7113-amputation-rule-cap
Source context
38 CFR 4.104; 7113; Current DC 7113 educational pathway.

20% (DC 7113, upper extremity, floor)

Next: 40%

No cardiac involvement, and chronic edema or stasis dermatitis (without ulceration or cellulitis), affecting an upper extremity.

What separates the next level: 40 percent applies once ulceration or cellulitis is also documented; 30 percent applies for the identical finding in a lower extremity instead.

Review CFR criteria, examples, and evidence
Official CFR language
Upper extremity -- 20.
Qualification explanation
Reached when chronic edema OR stasis dermatitis is documented for an upper extremity, without ulceration, cellulitis, or cardiac involvement. DC 7113's lowest stated tier.
Examples
Records document stasis dermatitis in the affected arm, attributed to a documented traumatic arteriovenous fistula, without ulceration, cellulitis, or cardiac involvement.
Medical evidence
Artery and Vein Conditions DBQ; Vascular examination records documenting edema or dermatitis findings by extremity
Functional impact examples
DC 7113's lowest stated finding overall.
Common misconceptions
Not yet populated
Related topics
dc7113-amputation-rule-cap
Source context
38 CFR 4.104; 7113; Current DC 7113 educational pathway.

40% (DC 7118, ceiling tier)

Highest listed pathway

Attacks without laryngeal involvement lasting one to seven days or longer and occurring more than eight times a year, or attacks with laryngeal involvement of any duration occurring more than twice a year.

What separates the next level: 20 percent applies at the next lower documented frequency for either pattern.

Review CFR criteria, examples, and evidence
Official CFR language
Attacks without laryngeal involvement lasting one to seven days or longer and occurring more than eight times a year, or; attacks with laryngeal involvement of any duration occurring more than twice a year -- 40.
Qualification explanation
Reached by either of two documented attack patterns: high-frequency non-laryngeal attacks, or laryngeal-involvement attacks occurring more than twice a year.
Examples
Records document angioneurotic edema attacks with laryngeal involvement occurring four times in the past year.
Medical evidence
Artery and Vein Conditions DBQ; Records documenting attack frequency, duration, and whether laryngeal involvement is present
Functional impact examples
DC 7118's most severe documented attack pattern.
Common misconceptions
Laryngeal-involvement attacks reach this tier at a lower frequency (more than twice a year) than non-laryngeal attacks (more than eight times a year) -- the two branches are not symmetrical.
Related topics
dc7118-dc7119-no-zero-floor
Source context
38 CFR 4.104; 7118; Current DC 7118 educational pathway.

20% (DC 7118)

Next: 40%

Attacks without laryngeal involvement lasting one to seven days and occurring five to eight times a year, or attacks with laryngeal involvement of any duration occurring once or twice a year.

What separates the next level: 40 percent applies at the higher documented frequency; 10 percent applies at the lower documented frequency for non-laryngeal attacks. DC 7118's text states no tier for a laryngeal-involvement attack occurring less than once a year.

Review CFR criteria, examples, and evidence
Official CFR language
Attacks without laryngeal involvement lasting one to seven days and occurring five to eight times a year, or; attacks with laryngeal involvement of any duration occurring once or twice a year -- 20.
Qualification explanation
Reached by either of two documented attack patterns, one tier below the 40 percent ceiling.
Examples
Records document angioneurotic edema attacks without laryngeal involvement occurring six times in the past year.
Medical evidence
Artery and Vein Conditions DBQ; Records documenting attack frequency, duration, and whether laryngeal involvement is present
Functional impact examples
A middle-tier documented attack pattern.
Common misconceptions
Not yet populated
Related topics
dc7118-dc7119-no-zero-floor
Source context
38 CFR 4.104; 7118; Current DC 7118 educational pathway.

10% (DC 7118, real floor -- no explicit 0 percent row)

Next: 20%

Attacks without laryngeal involvement lasting one to seven days and occurring two to four times a year.

What separates the next level: 20 percent applies at a higher documented frequency, or for any laryngeal-involvement attack occurring once or twice a year.

Review CFR criteria, examples, and evidence
Official CFR language
Attacks without laryngeal involvement lasting one to seven days and occurring two to four times a year -- 10.
Qualification explanation
DC 7118's lowest stated tier -- reached only for non-laryngeal attacks occurring two to four times a year.
Examples
Records document angioneurotic edema attacks without laryngeal involvement occurring three times in the past year.
Medical evidence
Artery and Vein Conditions DBQ; Records documenting attack frequency and duration
Functional impact examples
DC 7118's lowest documented qualifying attack pattern.
Common misconceptions
Confirmed via two independent primary sources: DC 7118 has NO explicit 0 percent tier. Non-laryngeal attacks occurring fewer than two times a year, and any laryngeal-involvement attack occurring less than once a year, have no stated tier at all -- resolved as a disclosed 38 CFR 4.31 no-qualifying-criterion outcome, never a guessed 0 percent.
Related topics
dc7118-dc7119-no-zero-floor
Source context
38 CFR 4.104; 7118; Current DC 7118 educational pathway.

100% (DC 7119, ceiling tier)

Highest listed pathway

Characteristic attacks occurring more than once a day, lasting an average of more than two hours each, responding poorly to treatment, and restricting most routine daily activities.

What separates the next level: 60 percent applies with the same frequency, duration, and poor treatment response, but without restricting most routine daily activities.

Review CFR criteria, examples, and evidence
Official CFR language
Characteristic attacks that occur more than once a day, last an average of more than two hours each, respond poorly to treatment, and that restrict most routine daily activities -- 100.
Qualification explanation
Reached when all four elements (frequency, duration, treatment response, and functional restriction) are documented together.
Examples
Records document burning pain attacks in the hands and feet occurring twice daily, averaging three hours each, responding poorly to treatment, and preventing most routine daily activities.
Medical evidence
Artery and Vein Conditions DBQ; Records documenting attack frequency, duration, treatment response, and functional restriction
Functional impact examples
DC 7119's most severe documented attack pattern.
Common misconceptions
DC 7119's evaluations are for the disease as a whole, regardless of the number of extremities involved -- see the whole-condition disclosure below.
Related topics
dc7119-whole-condition-non-bilateral; dc7118-dc7119-no-zero-floor
Source context
38 CFR 4.104; 7119; Current DC 7119 educational pathway.

60% (DC 7119)

Next: 100%

Characteristic attacks occurring more than once a day, lasting an average of more than two hours each, responding poorly to treatment, but not restricting most routine daily activities.

What separates the next level: 100 percent applies once most routine daily activities are also restricted; 30 percent applies once attacks respond to treatment instead of responding poorly.

Review CFR criteria, examples, and evidence
Official CFR language
Characteristic attacks that occur more than once a day, last an average of more than two hours each, and respond poorly to treatment, but that do not restrict most routine daily activities -- 60.
Qualification explanation
Reached with the same frequency, duration, and treatment response as the 100 percent tier, but without the functional-restriction element.
Examples
Records document burning pain attacks occurring twice daily, averaging three hours each, responding poorly to treatment, without preventing most routine daily activities.
Medical evidence
Artery and Vein Conditions DBQ; Records documenting attack frequency, duration, treatment response, and functional restriction
Functional impact examples
Significant documented attacks, one tier below DC 7119's ceiling.
Common misconceptions
Not yet populated
Related topics
dc7119-whole-condition-non-bilateral
Source context
38 CFR 4.104; 7119; Current DC 7119 educational pathway.

30% (DC 7119)

Next: 60%

Characteristic attacks that occur daily or more often but respond to treatment.

What separates the next level: 60 percent applies once treatment response becomes poor instead; 10 percent applies at a lower documented frequency.

Review CFR criteria, examples, and evidence
Official CFR language
Characteristic attacks that occur daily or more often but that respond to treatment -- 30.
Qualification explanation
Reached when attacks occur at least daily and respond to treatment, distinguishing this tier from the 60/100 percent tiers' poor treatment response.
Examples
Records document burning pain attacks occurring daily, responding to treatment.
Medical evidence
Artery and Vein Conditions DBQ; Records documenting attack frequency and treatment response
Functional impact examples
Frequent documented attacks that respond to treatment.
Common misconceptions
Not yet populated
Related topics
dc7119-whole-condition-non-bilateral
Source context
38 CFR 4.104; 7119; Current DC 7119 educational pathway.

10% (DC 7119, real floor -- no explicit 0 percent row)

Next: 30%

Characteristic attacks that occur less than daily but at least three times a week and respond to treatment.

What separates the next level: 30 percent applies once attacks occur daily or more often.

Review CFR criteria, examples, and evidence
Official CFR language
Characteristic attacks that occur less than daily but at least three times a week and that respond to treatment -- 10.
Qualification explanation
DC 7119's lowest stated tier -- reached when attacks occur at least three times a week (but less than daily) and respond to treatment.
Examples
Records document burning pain attacks occurring four times a week, responding to treatment.
Medical evidence
Artery and Vein Conditions DBQ; Records documenting attack frequency and treatment response
Functional impact examples
DC 7119's lowest documented qualifying attack pattern.
Common misconceptions
Confirmed via two independent primary sources: DC 7119 has NO explicit 0 percent tier. Attacks occurring less than three times a week have no stated tier at all -- resolved as a disclosed 38 CFR 4.31 no-qualifying-criterion outcome, never a guessed 0 percent.
Related topics
dc7118-dc7119-no-zero-floor
Source context
38 CFR 4.104; 7119; Current DC 7119 educational pathway.

100% (DC 7123, only computable tier)

Highest listed pathway

A confirmed soft tissue sarcoma of vascular origin, while receiving active surgical, X-ray, antineoplastic chemotherapy, or other therapeutic treatment, and for six months after that treatment ends.

What separates the next level: There is no lower tier under DC 7123 while this window applies. Once treatment has been discontinued for six months or more, DC 7123's own Note dispatches to a residual rating determined by mandatory VA examination, disclosed but not computed.

Review CFR criteria, examples, and evidence
Official CFR language
Soft tissue sarcoma (of vascular origin) -- 100.
Qualification explanation
Reached by a confirmed diagnosis together with active treatment, or treatment that ended less than six months ago, matching the already-live Respiratory Neoplasms hub's DC 6819 pattern exactly.
Examples
Records document a confirmed soft tissue sarcoma of vascular origin diagnosis and ongoing or recently concluded (within six months) surgical, radiation, or chemotherapy treatment.
Medical evidence
Artery and Vein Conditions DBQ; Oncology treatment records; Pathology or biopsy confirming the diagnosis; Records documenting treatment type and dates, including any cessation date
Functional impact examples
Currently undergoing chemotherapy, radiation, surgery, or another therapeutic procedure for a diagnosed vascular sarcoma.; Treatment ended within the last six months.
Common misconceptions
A vascular sarcoma diagnosis does not, by itself, continue at 100 percent indefinitely -- six months after treatment ends, DC 7123's own Note requires a mandatory VA examination to determine the appropriate rating for whatever residuals remain.
Related topics
dc7123-residual-dispatch
Source context
38 CFR 4.104; 7123; Current DC 7123 educational pathway.

Learn

Understand the details behind the criteria

Use these short guides to connect published terms with the records and observations that may clarify them.

This hub closes RSCH-040's final slice -- all 14 arteries-and-veins codes are now covered (read this first)

38 CFR 4.104's 'Diseases of the Arteries and Veins' range spans 14 live diagnostic codes (DC 7110-7124, excluding DC 7101, Hypertension, already its own hub). This hub covers the last six: DC 7110, 7112, 7113, 7118, 7119, and 7123.

  • The four sibling hubs already built from this same range are Peripheral Arterial Disease / Aneurysm / Buerger's Disease (DC 7111/7114/7115), Varicose Veins / Post-Phlebitic Syndrome (DC 7120/7121), Cold Injury Residuals (DC 7122), and Raynaud's Disease / Raynaud's Syndrome (DC 7117/7124).
  • With this hub, all 14 live diagnostic codes in the DC 7110-7124 range are covered somewhere across five hubs. DC 7116 is a numeric gap in the range, confirmed removed 1998-01-12 -- not a missing build, a genuinely retired code.
  • This is disclosed clearly rather than assumed comprehensive of every vascular condition in 38 CFR 4.104 -- DC 7101 (Hypertension) remains its own separate hub outside this range.

Records to review: Records confirming the specific diagnostic code documented for the vascular condition.

DC 7110's post-surgical residuals name two textually distinct, unconfirmed destinations (read this first)

Once DC 7110's six-month post-surgical-discharge window closes, DC 7110's own text splits into two separate residual determinations, neither of which names a confirmed destination code. RatingScope discloses both, kept clearly distinct, and computes neither.

  • (a) Cardiovascular residuals: DC 7110's Note states, 'Evaluate post-surgical residuals under the General Rating Formula.' The only rating formula with that exact name anywhere in 38 CFR 4.104 is the General Rating Formula for Diseases of the Heart, already live in the Heart Conditions hub, making it the single plausible candidate -- but DC 7110's own text never names it explicitly. This is different from DC 7111 (aneurysm, any large artery), whose own text explicitly says 'Evaluate under DC 7114.' RatingScope discloses the Heart Conditions cross-reference as an unconfirmed, not a confirmed, destination and does not compute a result.
  • (b) Non-cardiovascular residuals: DC 7110's own separate freestanding line reads, 'Evaluate non-cardiovascular residuals of surgical correction according to organ systems affected.' This is a wholly different, fully unnamed dispatch with no textual candidate at all -- disclosed separately from (a), never merged into one note, and never computed.
  • These two disclosures are deliberately kept distinct in this hub's own copy and in the underlying registry content, because conflating them would imply a false confidence that both branches point to the same destination -- they do not.

Records to review: Surgical and hospital discharge records establishing the six-month post-surgical timeline; Records documenting any cardiovascular or non-cardiovascular residual findings, once the window has closed.

DC 7112's symptomatic and post-surgical branches are fully open dispatches

DC 7112 (Aneurysm, any small artery) computes only its 0 percent asymptomatic tier. Its Note's symptomatic branch and post-surgical branch both dispatch to an unnamed 'body system affected,' with no destination code at all.

  • DC 7112's Note, verbatim: 'If symptomatic, evaluate according to body system affected. Following surgery, evaluate residuals under the body system affected.' Neither sentence names a specific diagnostic code.
  • This matches DC 6820's (benign respiratory neoplasms) already-live open-dispatch precedent in the Respiratory Neoplasms hub -- but DC 7112 does have one real computable tier (0 percent, asymptomatic), unlike DC 6820, so its shape is closer to DC 6819's hybrid pattern: compute the one clean tier, disclose the rest.
  • DC 7112 (any small artery) is not the same code as DC 7111 (any large artery, other than aorta), which is already built in the Peripheral Arterial Disease / Aneurysm / Buerger's Disease hub -- the two names are similar but the codes and their rating structures are different.

Records to review: Imaging documenting the small artery aneurysm and symptom status; Surgical records documenting any residuals, if surgery has occurred.

DC 7113 is confirmed reached by the 38 CFR 4.68 amputation-rule cap

38 CFR 4.68's general amputation-rule cap applies to disabilities of an extremity generally, not a fixed diagnostic-code list -- and DC 7113's own tiers are explicitly differentiated by upper and lower extremity. This is a confirmed fact, disclosed here, not automated anywhere in this repository yet.

  • 38 CFR 4.68, verbatim: 'The combined rating for disabilities of an extremity shall not exceed the rating for the amputation at the elective level, were amputation to be performed.'
  • DC 7113 is confirmed on `docs/NON_COMBINATION_RULE_REGISTER.md` section 5.8's list of per-extremity vascular codes reached by this cap, alongside the already-disclosed codes in the Peripheral Arterial Disease, Varicose Veins / Post-Phlebitic Syndrome, Raynaud's Disease / Raynaud's Syndrome, and Cold Injury Residuals hubs.
  • This repository does not compute the 38 CFR 4.68 cap anywhere yet -- a known, previously disclosed, repository-wide limitation, not specific to this hub. A veteran or representative combining a DC 7113 rating with other ratings for the same extremity should confirm the amputation-rule cap separately.

Records to review: Records documenting any other ratings for the same extremity affected by the traumatic arteriovenous fistula.

DC 7118 and DC 7119 both have no explicit 0 percent row

Neither Angioneurotic Edema (DC 7118) nor Erythromelalgia (DC 7119) states a 0 percent tier. A documented case below the lowest stated tier for either code resolves to the general 38 CFR 4.31 no-qualifying-criterion rule, never a guessed 0 percent.

  • Confirmed via two independent primary sources for both codes: DC 7118's lowest tier is 10 percent (non-laryngeal attacks, two to four times a year); DC 7119's lowest tier is 10 percent (attacks at least three times a week but less than daily, responding to treatment). Neither code names any tier below those thresholds.
  • This matches the already-established below-threshold pattern used elsewhere in this repository (for example, DC 5275 in the Shortening/Skull/Ribs/Coccyx hub, and Fibromyalgia's DC 5025) -- a documented fact pattern below the lowest stated tier resolves to a disclosed 38 CFR 4.31 outcome, not a fabricated 0 percent registry row.
  • For DC 7118 specifically, a laryngeal-involvement attack occurring less than once a year also falls below its own lowest laryngeal threshold and resolves the same way.

Records to review: Records documenting attack frequency, duration, and (for DC 7118) whether laryngeal involvement is present.

DC 7119 is evaluated as a whole, not eligible for the bilateral factor

DC 7119's own Note states its evaluations are for the disease as a whole, regardless of the number of extremities involved -- the same whole-condition, non-bilateral treatment already disclosed for Raynaud's DC 7117/7124.

  • DC 7119's Note, verbatim: 'These evaluations are for the disease as a whole, regardless of the number of extremities involved.'
  • This means DC 7119 is NOT eligible for the 38 CFR 4.26 bilateral factor, since the bilateral factor requires two separately rated paired-extremity disabilities to combine -- DC 7119 never produces more than one rating in the first place.
  • This mirrors the already-live Raynaud's Disease / Raynaud's Syndrome hub's own disclosure of the identical whole-condition language in DC 7117 and DC 7124.

Records to review: Records documenting attack findings collectively, since one evaluation covers all affected extremities together.

After six months post-treatment, DC 7123 dispatches to residuals (not computed)

DC 7123's own Note requires a mandatory VA examination six months after treatment ends, to determine the appropriate rating for whatever residual condition remains. RatingScope does not compute or guess which diagnostic code or percentage that would be.

  • DC 7123's Note, verbatim: 'A rating of 100 percent shall continue beyond the cessation of any surgical, X-ray, antineoplastic chemotherapy or other therapeutic procedure. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e) of this chapter. If there has been no local recurrence or metastasis, rate on residuals.'
  • This is the identical shape to the already-live Respiratory Neoplasms hub's DC 6819 (malignant respiratory neoplasm): a flat 100 percent tier during active treatment and for six months after, then a disclosed, uncomputed residual determination.
  • This hub computes only the 100 percent rating that applies during active treatment and within the six-month window after treatment ends. It does not compute, estimate, or guess at the residual rating a mandatory VA examination would produce after that window closes.

Records to review: Oncology treatment and follow-up records documenting treatment cessation date; Mandatory VA examination findings, once performed.

Evidence

Evidence that may clarify the published criteria

Records documenting which diagnosis applies (aortic aneurysm, small artery aneurysm, traumatic arteriovenous fistula, angioneurotic edema, erythromelalgia, or vascular sarcoma)

Establishes which of DC 7110, 7112, 7113, 7118, 7119, or 7123 applies.

Not required beyond the diagnosis itself once one type is confirmed.

Imaging documenting aneurysm diameter, symptom status, and any surgical recommendation or timeline

The core evidence distinguishing DC 7110's 100/0 percent tiers and its post-surgical disclosure.

Only relevant to an aortic aneurysm (DC 7110) diagnosis.

Cardiology and vascular examination records documenting heart involvement, edema, dermatitis, ulceration, or cellulitis findings by extremity

The core evidence distinguishing DC 7113's six tiers.

Only relevant to a traumatic arteriovenous fistula (DC 7113) diagnosis.

Records documenting attack frequency, duration, laryngeal involvement, treatment response, and functional restriction

The core evidence distinguishing DC 7118's and DC 7119's tiers.

Only relevant to an angioneurotic edema (DC 7118) or erythromelalgia (DC 7119) diagnosis.

Oncology diagnosis and treatment records, including pathology confirming vascular origin

Establishes DC 7123's diagnosis and the treatment-status timeline distinguishing its 100 percent tier from its disclosed residual dispatch.

Only relevant to a soft tissue sarcoma of vascular origin (DC 7123) diagnosis.

Artery and Vein Conditions DBQ

VA's examination form covering this section's diagnostic codes.

A DBQ is one common evidence source, not the only way to document these findings.

DBQ

What an artery and vein examination commonly documents

VA publishes an Artery and Vein Conditions DBQ covering this section's diagnostic codes. RatingScope reads whatever is documented; it does not infer undocumented findings or determine which diagnostic code applies.

  • Diagnosis (aortic aneurysm, small artery aneurysm, traumatic arteriovenous fistula, angioneurotic edema, erythromelalgia, or vascular sarcoma)
  • Aneurysm size, symptom status, and surgical timeline, if DC 7110 or DC 7112
  • Cardiac, skin, and tissue findings by extremity, if DC 7113
  • Attack frequency, duration, laryngeal involvement, treatment response, and functional restriction, if DC 7118 or DC 7119
  • Treatment status and cessation date, if DC 7123

Terminology

Plain-English terms

Traumatic arteriovenous fistula

An injury that creates a direct connection between an artery and a vein, which can strain the heart or affect the skin and tissue of the affected limb over time.

DC 7113's own six-tier ladder rates this finding by cardiac involvement first, then by extremity and skin/tissue findings.

Artery and Vein Conditions DBQ; dc7113-amputation-rule-cap

Angioneurotic edema

Repeated swelling episodes that can sometimes affect the throat, rated by how often they occur.

DC 7118's own three-tier ladder rates this finding by attack frequency, duration, and whether laryngeal involvement is present.

Artery and Vein Conditions DBQ; dc7118-dc7119-no-zero-floor

Erythromelalgia

A condition causing burning pain and redness in the hands or feet, typically triggered by warmth, rated for the disease as a whole rather than per limb.

DC 7119's own definition, confirmed verbatim, and its own Note that evaluations apply as a whole regardless of the number of extremities involved.

Artery and Vein Conditions DBQ; dc7119-whole-condition-non-bilateral

General Rating Formula for Diseases of the Heart

The shared scoring system VA uses for most heart conditions, based on how much physical activity a person can tolerate before symptoms occur.

The only rating formula with the exact name 'General Rating Formula' anywhere in 38 CFR 4.104, making it the single plausible (but textually unconfirmed) candidate for DC 7110's post-surgical cardiovascular residual dispatch.

Cardiology records documenting post-surgical cardiovascular residuals; dc7110-two-distinct-dispatches

TDIU

Even if the schedular rating for Aneurysm, Arteriovenous Fistula, Angioneurotic Edema, Erythromelalgia, and Vascular Sarcoma does not reach 100 percent, TDIU may still provide a pathway to compensation at the 100 percent rate, based on unemployability from this and/or other service-connected disabilities combined.

A lower schedular percentage does not by itself foreclose TDIU eligibility -- this hub computes only the schedular percentage for this specific condition and does not determine TDIU eligibility.

Employment history; vocational impact documentation; occupational impairment

Common Questions

Questions veterans commonly ask

Does this hub cover the whole arteries-and-veins schedule now?

Yes, across five hubs. This hub covers the final six diagnostic codes (DC 7110, 7112, 7113, 7118, 7119, 7123) not covered by the four already-live sibling hubs: Peripheral Arterial Disease / Aneurysm / Buerger's Disease, Varicose Veins / Post-Phlebitic Syndrome, Cold Injury Residuals, and Raynaud's Disease / Raynaud's Syndrome. Together, all 14 live diagnostic codes in 38 CFR 4.104's DC 7110-7124 range are now covered.

What happens to an aortic aneurysm after surgery?

DC 7110's own Note splits the post-surgical residual determination into two textually distinct, unconfirmed destinations: cardiovascular residuals reference 'the General Rating Formula' without naming it explicitly (the Heart Conditions hub's General Rating Formula for Diseases of the Heart is the single plausible candidate, but not a confirmed one), and non-cardiovascular residuals name no destination at all. RatingScope discloses both separately and computes neither.

How does VA rate a small artery aneurysm?

DC 7112's only computable tier is 0 percent, for an asymptomatic small artery aneurysm. If symptomatic, or following surgery, DC 7112's own Note dispatches to an unnamed body system with no destination code at all -- a fully open dispatch RatingScope discloses but does not compute.

How does VA rate a traumatic arteriovenous fistula?

By a six-tier ladder from 100 percent (high-output heart failure) down to 20 percent (chronic edema or stasis dermatitis in an upper extremity, without cardiac involvement), based first on cardiac findings, then on extremity and skin/tissue findings.

Does the amputation rule cap a DC 7113 rating?

Yes. DC 7113 is confirmed reached by 38 CFR 4.68's general amputation-rule cap for disabilities of an extremity, the same disclosed limitation already applied to the sibling per-extremity vascular hubs. This repository does not compute the 4.68 cap anywhere yet -- disclosed, not automated.

Do angioneurotic edema and erythromelalgia have a 0 percent tier?

No. Neither DC 7118 nor DC 7119 states a 0 percent tier. A documented case below the lowest stated tier for either code resolves to the general 38 CFR 4.31 no-qualifying-criterion rule, never a guessed 0 percent.

Does the bilateral factor apply to erythromelalgia?

No. DC 7119's own Note states its evaluations are for the disease as a whole, regardless of the number of extremities involved -- the same whole-condition, non-bilateral treatment already disclosed for Raynaud's DC 7117/7124.

What happens after treatment for a vascular sarcoma ends?

The 100 percent rating continues for six months after treatment ends. After that window, DC 7123's Note requires a mandatory VA examination to determine the appropriate rating for the residual condition, the same 'rate on residuals' pattern already live for Respiratory Neoplasms' DC 6819. RatingScope does not compute or guess at that residual rating.

If my schedular rating for Aneurysm, Arteriovenous Fistula, Angioneurotic Edema, Erythromelalgia, and Vascular Sarcoma is below 100%, can I still be compensated at the 100% rate?

Possibly, through TDIU (Total Disability rating based on Individual Unemployability, 38 CFR 4.16) -- a separate pathway to 100 percent compensation based on unemployability, from this and/or other service-connected disabilities combined, independent of whether the schedular rating itself reaches 100 percent. This hub computes only the schedular percentage and does not determine TDIU eligibility.

Preparation

What to have nearby

  • Confirmed diagnosis (aortic aneurysm, small artery aneurysm, traumatic arteriovenous fistula, angioneurotic edema, erythromelalgia, or vascular sarcoma)

    Determines which of DC 7110, 7112, 7113, 7118, 7119, or 7123 applies.

  • Aneurysm size, symptom status, and surgical timeline, if applicable

    The core facts distinguishing DC 7110's and DC 7112's computable tiers.

  • Cardiac, skin, and tissue findings by extremity, if a traumatic arteriovenous fistula

    The core facts distinguishing DC 7113's six tiers.

  • Attack frequency, duration, laryngeal involvement, treatment response, and functional restriction, if angioneurotic edema or erythromelalgia

    The core facts distinguishing DC 7118's and DC 7119's tiers.

  • Treatment status and cessation date, if a vascular sarcoma

    DC 7123's 100 percent tier depends on whether treatment is active or ended within the last six months.

Ready when you are

Compare documented aneurysm, arteriovenous fistula, angioneurotic edema, erythromelalgia, and vascular sarcoma findings

Use the diagnosis and finding language already documented in your records. Do not upload records or enter Social Security numbers, claim numbers, full dates of birth, or other sensitive identifiers. RatingScope does not infer missing findings, determine which diagnosis applies, or compute DC 7110's, DC 7112's, or DC 7123's disclosed open dispatches.

Informational guidance only. RatingScope does not predict, decide, or guarantee VA outcomes.

Compare my aneurysm, fistula, angioedema, erythromelalgia, or vascular sarcoma records

Learn More

Continue Understanding

Claims Process: exam preparation

General claim-exam preparation guidance, not specific to this condition.

Open resource

Claims Process: evidence checklist

General evidence-gathering guidance, not specific to this condition.

Open resource

38 CFR 4.104 - Diseases of the Arteries and Veins (Schedule of ratings)

Official eCFR source for the published DC 7110/7112/7113/7118/7119/7123 percentage descriptions.

Open resource

VA Artery and Vein Conditions Disability Benefits Questionnaire

Official VA form index.

Open resource

38 CFR 4.16 - Total disability ratings for compensation based on unemployability (TDIU)

Official source for TDIU, a separate pathway to 100 percent compensation based on unemployability, independent of the schedular percentage. This hub does not determine TDIU eligibility.

Open resource

Secondary conditions

Conditions commonly connected to Aneurysm, Arteriovenous Fistula, Angioneurotic Edema, Erythromelalgia, and Vascular Sarcoma

No commonly documented secondary connections are tracked for Aneurysm, Arteriovenous Fistula, Angioneurotic Edema, Erythromelalgia, and Vascular Sarcoma yet.

Keep going

Compare a percentage level and combined-rating math, or review evidence context.

See all tools

Percentage Guide

See what each percentage level means for your condition, then use the whole-person calculator to combine more than one rating.

Open Percentage Guide

Evidence Categories

Understand common evidence categories and what they can clarify without treating them as a checklist.

Review evidence categories